Call for expressions of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee

Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Date of authorisation: 15/09/2022, Revision: 3, Status: Lapsed

PSUSA/00000843/202501

Medicines authorised during pandemic

Paediatric investigation plans: Templates and forms

Clinical Trials Information System (CTIS): Walk-in clinic November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 November 2025, 16:00 (CET) to 19 November 2025, 17:00 (CET)

Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Date of authorisation: 08/05/2017, Revision: 18, Status: Authorised

PSUSA/00010915/202501

PSUSA/00000259/202502

Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 28, Status: Authorised